Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash, it is anticipated that the cash runway would ...

Net proceeds anticipated to extend cash runway into first quarter of 2027, beyond expected FDA submission; if warrants are exercised in full for cash, it is anticipated that the cash runway would ...

CAP accreditation, widely recognized as the gold standard in laboratory quality assurance, complements CNSide Diagnostics' ...

Institutional financing supports pivotal prospective clinical advancement and commercialization of Mammogen’s RNA-powered ...

International medical technology and cybersecurity company Sectra (STO: SECT B) announces that Grady Health System, one of the largest health systems in the US, is now live with Sectra Amplifier ...

Together with the MALDI Biotyper ® CA System and the Bruker Arc™ automated sample preparation solution for positive blood cultures, this innovative rapid AST workflow under development is expected to ...

Product Revenue -- $0.4 million, decreased from $0.8 million, reflecting limited commercial activity and ongoing investment ...

At ASMS, SCIEX, a Danaher company and leader in life science analytical technologies, launched the novus V55 system - a ...

A team of engineers at the University of Florida has developed a new form of CRISPR technology that could make diagnostics and treatments safer, more precise, and more affordable, while opening the ...

Detecting melanoma before it becomes visible is a major challenge in dermatology. Now, with researchers from Université de Montréal, scientists at Université du Québec's Institut national de la ...

Detailed price information for Lucid Diagnostics Inc (LUCD-Q) from The Globe and Mail including charting and trades.